» Articles » PMID: 35162872

Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use

Abstract

Using cannabis to reduce psychological and physical distress, referred to as self-medication, is a significant risk factor for cannabis use disorder. To better understand this high-risk behavior, a sample of 290 young adults (ages 18-25; 45.6% female) were recruited from two U.S. universities in January and February of 2020 to complete a survey about their cannabis use and self-medication. Results: seventy-six percent endorsed using cannabis to reduce problems such as anxiety, sleep, depression, pain, loneliness, social discomfort, and concentration. When predicting reasons for self-medication with cannabis, logistic regression models showed that lower CUDIT-R scores, experiencing withdrawal, living in a state where cannabis was illegal, and being female were all associated with higher rates of self-medication. Withdrawal symptoms were tested to predict self-medication with cannabis, and only insomnia and loss of appetite were significant predictors. To further explore why young adults self-medicate, each of the original predictors were regressed on seven specified reasons for self-medication. Young adults experiencing withdrawal were more likely to self-medicate for pain. Participants living where cannabis is legal were less likely to self-medicate for anxiety and depression. Living where cannabis is illegal also significantly predicted self-medicating for social discomfort-though the overall model predicting social discomfort was statistically non-significant. Finally, female participants were more likely to self-medicate for anxiety. These results suggest widespread self-medication among young adults with likely CUD and underscore the complexity of their cannabis use. The findings have implications for understanding why young adults use cannabis in relation to psychological and physical distress and for accurately treating young adults with cannabis use disorder.

Citing Articles

Changes in Cannabis Use Patterns in Psychiatric Populations Pre- and Post-Legalization of Recreational Cannabis Use in Canada: A Repeated Cross-Sectional Survey.

Sorkhou M, Johnstone S, Weinberger A, Cooper Z, Sanches M, Castle D Cannabis. 2025; 7(3):1-13.

PMID: 39781550 PMC: 11705070. DOI: 10.26828/cannabis/2024/000238.


Cannabinoids for treating psychiatric disorders in youth: a systematic review of randomized controlled trials.

Kock P, Badek A, Meyer M, Klaassen A, Walter M, Kindler J Child Adolesc Psychiatry Ment Health. 2024; 18(1):158.

PMID: 39696457 PMC: 11657296. DOI: 10.1186/s13034-024-00846-5.


Substance use and lifestyle risk factors for somatic disorders among psychiatric patients in Greenland.

Nielsen I, Sorensen L, Wichmand S, Heilmann P, Pedersen M Int J Circumpolar Health. 2024; 83(1):2421049.

PMID: 39462457 PMC: 11514394. DOI: 10.1080/22423982.2024.2421049.


Afrocentric Norms and Substance Use Behaviors Among Black Young Adults.

Lateef H, Azasu E, Boahen-Boaten B, Szlyk H, Frempong M, Cavazos-Rehg P Soc Work Public Health. 2024; 39(7):678-690.

PMID: 38990050 PMC: 11498946. DOI: 10.1080/19371918.2024.2376834.


Disproportionate increase in cannabis use among people with serious psychological distress and associations with psychiatric service use in the United States, 2009-2019.

Hyatt A, Flores M, Le Cook B Addict Behav. 2024; 157:108095.

PMID: 38905902 PMC: 11283347. DOI: 10.1016/j.addbeh.2024.108095.


References
1.
Goodhines P, Gellis L, Kim J, Fucito L, Park A . Self-Medication for Sleep in College Students: Concurrent and Prospective Associations With Sleep and Alcohol Behavior. Behav Sleep Med. 2017; 17(3):327-341. PMC: 5787047. DOI: 10.1080/15402002.2017.1357119. View

2.
Hanna R, Perez J, Ghose S . Cannabis and development of dual diagnoses: A literature review. Am J Drug Alcohol Abuse. 2016; 43(4):442-455. PMC: 5344774. DOI: 10.1080/00952990.2016.1213273. View

3.
Bahji A, Stephenson C, Tyo R, Hawken E, Seitz D . Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020; 3(4):e202370. PMC: 7146100. DOI: 10.1001/jamanetworkopen.2020.2370. View

4.
May A, Aupperle R, Stewart J . Dark Times: The Role of Negative Reinforcement in Methamphetamine Addiction. Front Psychiatry. 2020; 11:114. PMC: 7090143. DOI: 10.3389/fpsyt.2020.00114. View

5.
Adamson S, Kay-Lambkin F, Baker A, Lewin T, Thornton L, Kelly B . An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend. 2010; 110(1-2):137-43. DOI: 10.1016/j.drugalcdep.2010.02.017. View